Fore: Stock Predictions Daily Brief

Fore: Stock Predictions Daily Brief · Jan 14, 2026

Listen Later

Fore Stock Predictions Daily Brief - 2026-01-14

Target window: 2026-01-21

Top opportunities:

  • 1. $MU → $338.60 (+6.0%) @ 80% confidence
  • 2. $AMD → $235.84 (+5.2%) @ 75% confidence
  • 3. $CVNA → $419.88 (+4.7%) @ 73% confidence
  • 4. $APP → $649.82 (+4.8%) @ 68% confidence
  • 5. $ETHA → $24.81 (+4.6%) @ 68% confidence
  • 6. $WBD → $29.98 (+5.2%) @ 68% confidence
  • 7. $HOOD → $121.08 (+4.6%) @ 65% confidence
  • 8. $DELL → $134.75 (+5.3%) @ 73% confidence
  • 9. $WDC → $196.95 (+4.2%) @ 73% confidence
  • 10. $VRTX → $472.77 (+4.4%) @ 68% confidence

    • Story beats:

    • $MU: Micron (MU) is primed for gains amid AI memory supercycle, with sold-out HBM, earnings beats, price surges, and bullish technicals outweighing minor risks.
    • $AMD: AMD's AI innovations, analyst upgrades, and strong financials amid semiconductor boom position it for weekly upside of 4-5%.
    • $CVNA: CVNA poised for gains on strong fundamentals, analyst upgrades, technical momentum, and supportive macro trends despite mild risks.
    • $APP: APP's rebound, buyback support, analyst upgrades, and ad platform growth outweigh macro risks for bullish weekly potential.
    • $ETHA: ETHA poised for gains amid Fed easing, Bitcoin strength, and bullish ETH technicals overriding weak network metrics.
    • $WBD: WBD's stock poised for gains from intensifying M&A bidding war between PSKY and Netflix, plus solid operational metrics and technical support.
    • $HOOD: HOOD poised for upside on stellar Q3 results, analyst upgrades, crypto bill catalyst, and technical momentum amid supportive macro.
    • $DELL: Dell's strong AI server momentum, raised Q4 guidance, and analyst buys position it for a technical rebound amid robust IT demand.
    • $WDC: WDC poised for gains from AI storage boom, NAND/HDD tailwinds, strong Q1 results, tech catalysts, and bullish technicals.
    • $VRTX: Vertex Pharmaceuticals is primed for upside from imminent JOURNAVX and POVE data readouts, strong Q3 results, and gene therapy momentum, with technicals supporting a rebound.

      • Dashboards + charts: https://fore.markets/aggregated-forecast-report-v2?run_id=2026-01-14

      Video + captions also on fore.markets.

      ⚠️ Not financial advice. Markets involve risk. Terms: fore.markets/tos.html | Privacy: fore.markets/privacy.html.

      ...more
      View all episodesView all episodes
      Download on the App Store
      Fore: Stock Predictions Daily BriefBy foremarkets